PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1148027
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1148027
The Superdisintegrants Market size was valued at USD 490.7 Million in 2021, expanding at a CAGR of 7.2% from 2022 to 2028.
Superdisintegrants are one of the various excipient types utilized in the pharmaceutical industry for tablet-based medication administration. To assist them to dissolve when submerged in a liquid, superdisintegrants are added to solid dosage forms like pills or tablets. The tablet's increased surface area from breaking into smaller pieces speeds up medication release.
Market Dynamics:
The development of unique superdisintegrant mixtures is a significant advancement in the pharmaceutical sector. With the help of these preparations, manufacturers now have access to a wide range of superdisintegrants, such as co-processed excipients, which are made up of several synthetic superdisintegrants, natural and synthetic superdisintegrants, or synthetic superdisintegrants combined with other pharmaceutical excipients. The active components' fast action, helps to improve the way medications work. Disintegrants are specifically developed for use in the direct compression method of tablet formulations, which eliminates several wet and dry granulation-related processing steps. One of the fastest-growing drug delivery methods using superdisintegrants for direct compression is oral disintegrating tablets (ODTs). A favorable regulatory environment in the developed regions is also progressively supporting growth in the acceptance of innovative excipients. The creation and application of novel excipients have been supported by the International Pharmaceutical Excipients Council (IPEC). To reduce the expense and uncertainty associated with the use of innovative excipients in pharmaceutical formulations, the council has established a novel excipient review approach as an independent process. Therefore, the emergence of new superdisintegrants in the pharmaceutical industry is expected to drive market growth during the forecast period.
However, despite the expanding usage of excipients in medicines, the market for superdisintegrants still has a difficult time meeting up to the high standards set by regulators, consumers, drug manufacturers, and-most importantly-patients. Superdisintegrant production variations have an impact on both the important quality characteristics and the efficacy of drugs. Superdisintegrant concentration fluctuations from supplier to supplier or batch to batch have an impact on the interaction between excipients and drugs, which in turn has an impact on drug efficacy and quality.
COVID-19 Analysis:
The ongoing COVID-19 pandemic had a big effect on the bioanalytical and pharmaceutical industries, especially in the areas of therapeutic research and backing for ongoing drug trials. The dynamics of the industry were somewhat influenced by the difficulties faced by various existing procedures in managing the reduction in manpower at sites and the increased workloads for other COVID-19-related support. However, shortly, the business might slowly come back into existence due to increasing awareness of the higher risk of coronavirus infection among neurological patients. It has been demonstrated that in some patients, an overreactive reaction to the virus raises the risk of dementia, stroke, vascular diseases, and encephalitis. Orally disintegrating tablets are frequently employed as a therapy option for patients with neurological problems like these, therefore drug production is projected to experience a considerable increase, which will ultimately lead to good growth for the industry as a whole.
Geography: Segment Analysis
With the largest revenue share in the superdisintegrants market in 2021, North America dominated the market. A few significant market drivers are the rise in demand for generic medications, improved innovation in the production of superdisintegrants, and manufacturing methods. Additionally, some of the most prominent players in the market for superdisintegrants are based in North America.
However, during the projected period, Asia Pacific is anticipated to develop at the fastest rate. Growth in the Asia Pacific region is anticipated to be fueled by aspects such as rising outsourcing of excipients, including superdisintegrants, production of new superdisintegrants, and adoption of novel technologies (New drug delivery system).
Recent Development:
In March 2021, Formulationbio announced the Launch of Disintegrant Excipients for Pharmaceutical Preparation.
Key features of the study:
This proposed research study on the Superdisintegrants market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Superdisintegrants market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Superdisintegrants market
The impact of COVID-19 on the Superdisintegrants market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Superdisintegrants market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Superdisintegrants market, we have also included a competitive landscape and key innovator analysis for the Superdisintegrants market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Superdisintegrants market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Superdisintegrants market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SUPERDISINTEGRANTS MARKET KEY PLAYERS
BASF SE
DuPont
Ashland Global Holdings Inc.
Roquette Freres
DFE Pharma
JRS PHARMA
Asahi Kasei Corporation
Merck KGaA
Corel Pharma Chem
Avantor Performance Materials
NIPPO SODA CO., LTD.
Sigachi Industries
Colorcon
NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
GLOBAL SUPERDISINTEGRANTS MARKET, BY TYPE
Natural Superdisintegrants
Synthetic Superdisintegrants
Others
GLOBAL SUPERDISINTEGRANTS MARKET, BY FORMULATION
Tablets
Capsules
GLOBAL SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA
Gastrointestinal Diseases
Neurological Diseases
Oncology
Infectious Diseases
Cardiovascular Diseases
Hematological Diseases
Inflammatory Diseases
GLOBAL SUPERDISINTEGRANTS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA